Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

Whitehawk Therapeutics, Inc.

WHWK · Nasdaq · CIK 0001422142 · Healthcare · Biotechnology

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

6 Form 4 transaction lines observed in the same window
0 sales · 6 option, withholding, award, gift or other lines

Last qualifying purchase2021-08-26 · Dalal Anupam · $20.0M

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesNone
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Lennon David JamesCHIEF EXECUTIVE OFFICER
○
Giacobello Scott M.CHIEF FINANCIAL OFFICER
○
Dugan MargaretChief Medical Officer
○
Castelein CaleyDirector
○
BALL BRYANSee remarks
○
Dalal AnupamDirector
○
● Purchase▼ Sale○ Other

—

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2021-08-26 · Dalal Anupam.

Recent Form 4 activity

0Purchases
14Sales
12Other Form 4 lines
17SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING0 sale line(s) · context only
OTHER6 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
2,710,161
Previous report
2,726,765
Avg daily volume
382,262
Days to cover
7.1

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2021-08-26Dalal AnupamPurchase (P)Common Stock1,529,402USD 13.08USD 20,004,578SEC filing ↗
2021-08-26Dalal AnupamPurchase (P)Common Stock1,529,402USD 13.08USD 20,004,578SEC filing ↗
2021-08-26Castelein CaleyPurchase (P)Common Stock259,998USD 13.08USD 3,400,774SEC filing ↗

Form 4 evidence

26 transaction lines in the latest 365-day window; 103 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-05-14Dalal AnupamAward / grant (A)Common Stock1,275,510USD 3.92USD 4,999,999SEC filing ↗
2026-05-14Lennon David JamesAward / grant (A)Common Stock51,021USD 3.92USD 200,002SEC filing ↗
2026-05-14Giacobello Scott M.Award / grant (A)Common Stock38,265USD 3.92USD 149,999SEC filing ↗
Show recent Form 4 evidence (26 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-05-14Dalal AnupamAward / grant (A)Common Stock1,275,510USD 3.92USD 4,999,999SEC filing ↗
2026-05-14Lennon David JamesAward / grant (A)Common Stock51,021USD 3.92USD 200,002SEC filing ↗
2026-05-14Giacobello Scott M.Award / grant (A)Common Stock38,265USD 3.92USD 149,999SEC filing ↗
2026-05-14Dugan MargaretAward / grant (A)Common Stock19,132USD 3.92USD 74,997SEC filing ↗
2026-05-14Castelein CaleyAward / grant (A)Common Stock255,102USD 3.92USD 1,000,000SEC filing ↗
2026-05-14BALL BRYANAward / grant (A)Common Stock51,020USD 3.92USD 199,998SEC filing ↗
2026-04-16Giacobello Scott M.Sale (S)Common Stock141,600USD 4.13USD 584,808SEC filing ↗
2026-04-15Giacobello Scott M.Sale (S)Common Stock77,000USD 3.86USD 297,220SEC filing ↗
2026-04-14BALL BRYANSale (S)Common Stock92,460USD 3.64USD 336,554SEC filing ↗
2026-04-13BALL BRYANSale (S)Common Stock26,389USD 3.46USD 91,306SEC filing ↗
2026-04-10BALL BRYANSale (S)Common Stock6,596USD 3.43USD 22,624SEC filing ↗
2026-04-09BALL BRYANSale (S)Common Stock50,000USD 3.57USD 178,500SEC filing ↗
2026-04-09Lennon David JamesSale (S)Common Stock14,500USD 3.38USD 49,010SEC filing ↗
2026-04-08Lennon David JamesSale (S)Common Stock63,945USD 3.40USD 217,413SEC filing ↗
2026-04-07Lennon David JamesSale (S)Common Stock94,087USD 3.43USD 322,718SEC filing ↗
2026-04-06Lennon David JamesSale (S)Common Stock102,395USD 3.51USD 359,406SEC filing ↗
2026-04-02Lennon David JamesSale (S)Common Stock26,858USD 3.48USD 93,466SEC filing ↗
2026-04-01Lennon David JamesOption exercise / conversion (M)Common Stock775,828USD —USD —SEC filing ↗
2026-04-01Giacobello Scott M.Option exercise / conversion (M)Common Stock473,902USD —USD —SEC filing ↗
2026-04-01BALL BRYANOption exercise / conversion (M)Common Stock366,532USD —USD —SEC filing ↗
2026-03-02Lennon David JamesSale (S)Common Stock5,100USD 3.31USD 16,881SEC filing ↗
2026-03-02Giacobello Scott M.Sale (S)Common Stock2,594USD 3.31USD 8,586SEC filing ↗
2026-03-02BALL BRYANSale (S)Common Stock1,834USD 3.31USD 6,071SEC filing ↗
2026-03-01Lennon David JamesOption exercise / conversion (M)Common Stock16,250USD —USD —SEC filing ↗
2026-03-01Giacobello Scott M.Option exercise / conversion (M)Common Stock6,750USD —USD —SEC filing ↗
2026-03-01BALL BRYANOption exercise / conversion (M)Common Stock5,000USD —USD —SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerWHWK
CIK0001422142
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNasdaq

Data coverage

Local Form 4 history103 transaction lines from 2020-12-08 to 2026-05-14
3 P purchase lines · 63 S sale lines · 37 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.